Brief: Aspira Women's Health Says Got Nasdaq Notice Of A Delisting
14/07/2023 22:34
July 14 (Reuters) - Aspira Women's Health Inc AWH.O :
* ASPIRA WOMEN'S HEALTH - ON JULY 11, GOT NOTICE OF
DELISTING OR
FAILURE TO SATISFY CONTINUED LISTING RULE OR STANDARD; TRANSFER
OF LISTING FROM NASDAQ
Further company coverage: AWH.O
Recent news on Aspira Women's Health
See all newsBrief: Aspira Women’S Health Announces Receipt Of Delisting Notification From Nasdaq
Brief: Aspira Women's Health On April 4, Enters Equity Purchase Agreement With Triton Funds
Brief: Aspira Women's Health Files For Offering Up To 50 Units, 50 Mln Pre-Funded Units
Brief: Aspira Women's Health Interim CFO John Kallassy Resigns
Brief: Aspira Women's Health Fails To Regain Nasdaq Compliance